Company Profiles

driven by the PitchBook Platform

Abilita Bio

Abilita Bio
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
2 INVESTORS
Description

Developer of drugs targeting membrane proteins. The company discovers and develops therapeutic drugs and technologies to enable discovery and development of drugs targeting membrane proteins.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
3210 Merryfield Row
San Diego, CA 92121
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abilita Bio’s full profile, request a free trial.

Abilita Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 20-Sep-2016 Completed Startup
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Abilita Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0

Abilita Bio Executive Team (2)

Name Title Board
Seat
Contact
Info
Mauro Mileni Ph.D Founder & Chief Executive Officer
Rosario Billetta Chief Technology Officer